CN114058632A - Gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside - Google Patents
Gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside Download PDFInfo
- Publication number
- CN114058632A CN114058632A CN202111181146.7A CN202111181146A CN114058632A CN 114058632 A CN114058632 A CN 114058632A CN 202111181146 A CN202111181146 A CN 202111181146A CN 114058632 A CN114058632 A CN 114058632A
- Authority
- CN
- China
- Prior art keywords
- gene
- pncox11
- notoginsenoside
- synthesis
- regulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 64
- 230000015572 biosynthetic process Effects 0.000 title claims abstract description 24
- 229930189092 Notoginsenoside Natural products 0.000 title claims abstract description 22
- 238000003786 synthesis reaction Methods 0.000 title claims abstract description 19
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 13
- 230000001276 controlling effect Effects 0.000 title claims abstract description 10
- 239000002773 nucleotide Substances 0.000 claims abstract description 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 19
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 claims description 14
- 108090000365 Cytochrome-c oxidases Proteins 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 3
- 230000037361 pathway Effects 0.000 claims description 2
- 238000003259 recombinant expression Methods 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 241000180649 Panax notoginseng Species 0.000 abstract description 17
- 235000003143 Panax notoginseng Nutrition 0.000 abstract description 17
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract description 16
- 230000033228 biological regulation Effects 0.000 abstract description 10
- 239000002299 complementary DNA Substances 0.000 abstract description 9
- 239000012634 fragment Substances 0.000 abstract description 7
- 108091023040 Transcription factor Proteins 0.000 abstract description 6
- 102000040945 Transcription factor Human genes 0.000 abstract description 6
- 238000011160 research Methods 0.000 abstract description 6
- 238000011144 upstream manufacturing Methods 0.000 abstract description 6
- 238000000034 method Methods 0.000 abstract description 4
- 230000035897 transcription Effects 0.000 abstract description 2
- 238000013518 transcription Methods 0.000 abstract description 2
- 150000001413 amino acids Chemical group 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 239000013612 plasmid Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000013598 vector Substances 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- 244000131316 Panax pseudoginseng Species 0.000 description 5
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 241000208125 Nicotiana Species 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 230000004960 subcellular localization Effects 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 2
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000012880 LB liquid culture medium Substances 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 101000718529 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) Alpha-galactosidase Proteins 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 210000003763 chloroplast Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- 101150000874 11 gene Proteins 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- DXTYEWAQOXYRHZ-KKXDTOCCSA-N Ala-Phe-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N DXTYEWAQOXYRHZ-KKXDTOCCSA-N 0.000 description 1
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 1
- ZDILXFDENZVOTL-BPNCWPANSA-N Ala-Val-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDILXFDENZVOTL-BPNCWPANSA-N 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- MUXONAMCEUBVGA-DCAQKATOSA-N Arg-Arg-Gln Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(O)=O MUXONAMCEUBVGA-DCAQKATOSA-N 0.000 description 1
- UXJCMQFPDWCHKX-DCAQKATOSA-N Arg-Arg-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UXJCMQFPDWCHKX-DCAQKATOSA-N 0.000 description 1
- SLNCSSWAIDUUGF-LSJOCFKGSA-N Arg-His-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O SLNCSSWAIDUUGF-LSJOCFKGSA-N 0.000 description 1
- AIFHRTPABBBHKU-RCWTZXSCSA-N Arg-Thr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AIFHRTPABBBHKU-RCWTZXSCSA-N 0.000 description 1
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 1
- POOCJCRBHHMAOS-FXQIFTODSA-N Asn-Arg-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O POOCJCRBHHMAOS-FXQIFTODSA-N 0.000 description 1
- DXZNJWFECGJCQR-FXQIFTODSA-N Asn-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N DXZNJWFECGJCQR-FXQIFTODSA-N 0.000 description 1
- XOQYDFCQPWAMSA-KKHAAJSZSA-N Asn-Val-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOQYDFCQPWAMSA-KKHAAJSZSA-N 0.000 description 1
- PSLSTUMPZILTAH-BYULHYEWSA-N Asp-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PSLSTUMPZILTAH-BYULHYEWSA-N 0.000 description 1
- RQYMKRMRZWJGHC-BQBZGAKWSA-N Asp-Gly-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)N RQYMKRMRZWJGHC-BQBZGAKWSA-N 0.000 description 1
- AHWRSSLYSGLBGD-CIUDSAMLSA-N Asp-Pro-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AHWRSSLYSGLBGD-CIUDSAMLSA-N 0.000 description 1
- XWKBWZXGNXTDKY-ZKWXMUAHSA-N Asp-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O XWKBWZXGNXTDKY-ZKWXMUAHSA-N 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- XABFFGOGKOORCG-CIUDSAMLSA-N Cys-Asp-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O XABFFGOGKOORCG-CIUDSAMLSA-N 0.000 description 1
- 102100041024 Cytochrome c oxidase assembly protein COX11, mitochondrial Human genes 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 108010022535 Farnesyl-Diphosphate Farnesyltransferase Proteins 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- LZRMPXRYLLTAJX-GUBZILKMSA-N Gln-Arg-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O LZRMPXRYLLTAJX-GUBZILKMSA-N 0.000 description 1
- WQWMZOIPXWSZNE-WDSKDSINSA-N Gln-Asp-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O WQWMZOIPXWSZNE-WDSKDSINSA-N 0.000 description 1
- HNVFSTLPVJWIDV-CIUDSAMLSA-N Glu-Glu-Gln Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HNVFSTLPVJWIDV-CIUDSAMLSA-N 0.000 description 1
- HFXJIZNEXNIZIJ-BQBZGAKWSA-N Gly-Glu-Gln Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HFXJIZNEXNIZIJ-BQBZGAKWSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- BIAKMWKJMQLZOJ-ZKWXMUAHSA-N His-Ala-Ala Chemical compound C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1cnc[nH]1)C(O)=O BIAKMWKJMQLZOJ-ZKWXMUAHSA-N 0.000 description 1
- 101000748842 Homo sapiens Cytochrome c oxidase assembly protein COX11, mitochondrial Proteins 0.000 description 1
- CCHSQWLCOOZREA-GMOBBJLQSA-N Ile-Asp-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N CCHSQWLCOOZREA-GMOBBJLQSA-N 0.000 description 1
- OONBGFHNQVSUBF-KBIXCLLPSA-N Ile-Gln-Cys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CS)C(O)=O OONBGFHNQVSUBF-KBIXCLLPSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- YBKKLDBBPFIXBQ-MBLNEYKQSA-N Ile-Thr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)O)N YBKKLDBBPFIXBQ-MBLNEYKQSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- NCZIQZYZPUPMKY-PPCPHDFISA-N Lys-Ile-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NCZIQZYZPUPMKY-PPCPHDFISA-N 0.000 description 1
- GILLQRYAWOMHED-DCAQKATOSA-N Lys-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCCN GILLQRYAWOMHED-DCAQKATOSA-N 0.000 description 1
- PHKBGZKVOJCIMZ-SRVKXCTJSA-N Met-Pro-Arg Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PHKBGZKVOJCIMZ-SRVKXCTJSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- QCHNRQQVLJYDSI-DLOVCJGASA-N Phe-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 QCHNRQQVLJYDSI-DLOVCJGASA-N 0.000 description 1
- KAHUBGWSIQNZQQ-KKUMJFAQSA-N Phe-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KAHUBGWSIQNZQQ-KKUMJFAQSA-N 0.000 description 1
- HPECNYCQLSVCHH-BZSNNMDCSA-N Phe-Cys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N HPECNYCQLSVCHH-BZSNNMDCSA-N 0.000 description 1
- BFYHIHGIHGROAT-HTUGSXCWSA-N Phe-Glu-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BFYHIHGIHGROAT-HTUGSXCWSA-N 0.000 description 1
- MMPBPRXOFJNCCN-ZEWNOJEFSA-N Phe-Tyr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MMPBPRXOFJNCCN-ZEWNOJEFSA-N 0.000 description 1
- HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 1
- VYWNORHENYEQDW-YUMQZZPRSA-N Pro-Gly-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 VYWNORHENYEQDW-YUMQZZPRSA-N 0.000 description 1
- QCMYJBKTMIWZAP-AVGNSLFASA-N Pro-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 QCMYJBKTMIWZAP-AVGNSLFASA-N 0.000 description 1
- FYXCBXDAMPEHIQ-FHWLQOOXSA-N Pro-Trp-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CCCCN)C(=O)O FYXCBXDAMPEHIQ-FHWLQOOXSA-N 0.000 description 1
- VDHGTOHMHHQSKG-JYJNAYRXSA-N Pro-Val-Phe Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O VDHGTOHMHHQSKG-JYJNAYRXSA-N 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- HRNQLKCLPVKZNE-CIUDSAMLSA-N Ser-Ala-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O HRNQLKCLPVKZNE-CIUDSAMLSA-N 0.000 description 1
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 1
- RZUOXAKGNHXZTB-GUBZILKMSA-N Ser-Arg-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O RZUOXAKGNHXZTB-GUBZILKMSA-N 0.000 description 1
- VFWQQZMRKFOGLE-ZLUOBGJFSA-N Ser-Ser-Cys Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O VFWQQZMRKFOGLE-ZLUOBGJFSA-N 0.000 description 1
- ZSDXEKUKQAKZFE-XAVMHZPKSA-N Ser-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N)O ZSDXEKUKQAKZFE-XAVMHZPKSA-N 0.000 description 1
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 1
- BEBVVQPDSHHWQL-NRPADANISA-N Ser-Val-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O BEBVVQPDSHHWQL-NRPADANISA-N 0.000 description 1
- 102100037997 Squalene synthase Human genes 0.000 description 1
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 1
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 1
- QGVBFDIREUUSHX-IFFSRLJSSA-N Thr-Val-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O QGVBFDIREUUSHX-IFFSRLJSSA-N 0.000 description 1
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 1
- NOXKHHXSHQFSGJ-FQPOAREZSA-N Tyr-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NOXKHHXSHQFSGJ-FQPOAREZSA-N 0.000 description 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 1
- LDKDSFQSEUOCOO-RPTUDFQQSA-N Tyr-Thr-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LDKDSFQSEUOCOO-RPTUDFQQSA-N 0.000 description 1
- MIKHIIQMRFYVOR-RCWTZXSCSA-N Val-Pro-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C(C)C)N)O MIKHIIQMRFYVOR-RCWTZXSCSA-N 0.000 description 1
- VVIZITNVZUAEMI-DLOVCJGASA-N Val-Val-Gln Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCC(N)=O VVIZITNVZUAEMI-DLOVCJGASA-N 0.000 description 1
- 108091060592 XDNA Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000003855 cell nucleus Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000003967 crop rotation Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 108010069495 cysteinyltyrosine Proteins 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- PWAOOJDMFUQOKB-WCZZMFLVSA-N ginsenoside Re Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]3C(C)(C)[C@@H](O)CC[C@]3(C)[C@@H]3[C@@]([C@@]4(CC[C@@H]([C@H]4[C@H](O)C3)[C@](C)(CCC=C(C)C)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C)(C)C2)O[C@H](CO)[C@@H](O)[C@@H]1O PWAOOJDMFUQOKB-WCZZMFLVSA-N 0.000 description 1
- AOGZLQUEBLOQCI-UHFFFAOYSA-N ginsenoside-Re Natural products CC1OC(OCC2OC(OC3CC4(C)C(CC(O)C5C(CCC45C)C(C)(CCC=C(C)C)OC6OC(CO)C(O)C(O)C6O)C7(C)CCC(O)C(C)(C)C37)C(O)C(O)C2O)C(O)C(O)C1O AOGZLQUEBLOQCI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000013882 gravy Nutrition 0.000 description 1
- 108010050343 histidyl-alanyl-glutamine Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 108010025153 lysyl-alanyl-alanine Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 108010063431 methionyl-aspartyl-glycine Proteins 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 238000010397 one-hybrid screening Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 108010012581 phenylalanylglutamate Proteins 0.000 description 1
- 230000029279 positive regulation of transcription, DNA-dependent Effects 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 108010015796 prolylisoleucine Proteins 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000024053 secondary metabolic process Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- -1 sterol compounds Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000003521 tetracyclic triterpenoids Chemical class 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0053—Oxidoreductases (1.) acting on a heme group of donors (1.9)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y109/00—Oxidoreductases acting on a heme group of donors (1.9)
- C12Y109/03—Oxidoreductases acting on a heme group of donors (1.9) with oxygen as acceptor (1.9.3)
- C12Y109/03001—Cytochrome-c oxidase (1.9.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01021—Squalene synthase (2.5.1.21), i.e. farnesyl-disphosphate farnesyltransferase
Abstract
The invention discloses a gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside, wherein the nucleotide sequence of the gene PnCOX11 is shown as SEQ ID NO. 1. The invention takes the PnSS upstream promoter sequence of the gene as a research object, screens the transcription factor interacting with the promoter fragment from the panax notoginseng cDNA library by using a yeast single hybrid method, provides a new way for regulating and controlling the synthesis of notoginsenoside, and lays a foundation for researching the transcription regulation and control of the biosynthesis way of notoginsenoside.
Description
Technical Field
The invention relates to the technical field of genetic engineering, and mainly relates to a gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside.
Background
Pseudo-ginseng (Panax notoginseng (Burk.) F.H.Chen) is a perennial upright herbaceous plant of Panax of Araliaceae, and is one of the traditional famous and precious medicinal materials in China. Notoginsenoside (PNS) is the main medicinal active component of notoginseng, and is composed of various tetracyclic triterpenoid saponins. The research shows that the panax notoginseng saponins have better pharmacological activity in the aspects of central nervous system, cardiovascular and cerebrovascular systems, blood system, immune system, fibrosis resistance, aging resistance, tumor resistance and the like. The requirements of the pseudo-ginseng on the planting environment are strict, the growth cycle is long, the crop rotation obstacle is serious, the yield of the pseudo-ginseng is difficult to meet the market demand, and the sustainable development of the pseudo-ginseng industry is severely restricted. Notoginsenoside is mainly synthesized by mevalonic acid (MVA), and Squalene Synthase (SS) is a key enzyme, and has important regulation and control effects on triterpenes and sterols in plant body.
In recent years, the gene regulation of the secondary metabolic synthesis of medicinal plants becomes a research hotspot, and the completion of panax notoginseng genome sequencing provides a powerful research and application basis for the elucidation of the biosynthesis regulation mechanism of notoginsenoside and the development of traditional Chinese medicine. The transcription factor can act on promoter sequences at the upstream of a plurality of genes to realize 'multi-point regulation', and influence the expression of the plurality of genes related to the synthesis of secondary metabolites. The transcriptional activation of a Transcription factor (Transcription factor) on a gene is an important regulation link in the secondary metabolic process of plants, and has the advantage of 'multi-point regulation'.
The research shows that the transcription factor can influence the expression of key enzyme gene directly participating in the synthesis of notoginsenoside so as to realize the regulation and control of saponin anabolism. The gene PnSS is a key enzyme gene of a biosynthesis pathway of the triterpenoid saponin of panax notoginseng. PnSS is a key enzyme which is exclusively used in the branch metabolic flow of triterpenoid and sterol substance synthesis, and plays an important regulation role in the biosynthesis of triterpenoid and sterol compounds in plants. Patel et al inhibited the phenotype of the ginseng SS geneAfter that, it was found that the decrease of the amount of triterpene saponin synthesized and the increase of the expression level of SS in the adventitious roots of ginseng simultaneously increased the contents of phytosterol and ginsenoside. When SS and DS in the pseudo-ginseng cell line are co-overexpressed, the saponin content is obviously improved, wherein the ginsenoside Re content is 5-6 times of that of a control。
Disclosure of Invention
The invention provides a gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside, wherein the gene PnCOX11 is a cytochrome C oxidase 11 gene and has interaction with a promoter directly participating in a key enzyme gene PnSS for synthesizing notoginsenoside, so that synthesis of notoginsenoside is influenced.
The specific technical scheme is as follows:
the invention provides a gene PnCOX11, the nucleotide sequence of which is shown in SEQ ID NO. 1.
The present invention provides a recombinant expression vector comprising the gene PnCOX11 described above.
The invention provides a genetically engineered bacterium comprising the gene PnCOX11 described above.
The invention provides cytochrome C oxidase 11, wherein the amino acid sequence of the cytochrome C oxidase 11 is shown as SEQ ID No. 2.
The present invention provides a cytochrome C oxidase 11, wherein the cytochrome C oxidase 11 is obtained by encoding a gene PnCOX11 having a nucleotide sequence shown in SEQ ID NO. 1.
The invention also provides the use of the gene PnCOX11 as described above or of the cytochrome C oxidase 11 as described above in the interaction with the promoter of the gene PnSS.
The invention also provides the application of the gene PnCOX11 or the genetic engineering bacteria in regulating and controlling the synthesis of notoginsenoside.
Further, the regulatory pathways are: the protein coded by the gene PnCOX11 is combined with the promoter of the gene PnSS to regulate and control the synthesis of notoginsenoside.
The invention also provides application of the cytochrome C oxidase 11 in regulation and control of notoginsenoside synthesis.
Compared with the prior art, the invention has the following beneficial effects:
the invention takes the PnSS upstream promoter sequence of the gene as a research object, screens the transcription factor interacting with the promoter fragment from the panax notoginseng cDNA library by using a yeast single hybrid method, provides a new way for regulating and controlling the synthesis of notoginsenoside, and lays a foundation for researching the transcription regulation and control of the biosynthesis way of notoginsenoside.
Drawings
FIG. 1 is the result of predicting the secondary structure of PnCOX11 protein in example 3;
wherein, α -helix: the longest vertical line; extension chain: a second long vertical line; beta-turn: a third long vertical line; random curl: the shortest vertical line.
FIG. 2 shows the predicted results of the tertiary structure of PnCOX11 protein in example 3.
FIG. 3 is a phylogenetic tree of the PnCOX11 protein of example 3.
FIG. 4 shows the results of the X- α -gal chromogenic reaction in example 4, which verifies the interaction between PnSS (CK) and PnCOX 11.
FIG. 5 shows the results of the induced expression of PnCOX11 protein in example 5.
FIG. 6 is a subcellular localization map of PnCOX11 protein in example 6 (CK: 35S-sGFP).
Detailed Description
The present invention will be further described with reference to the following specific examples, which are only illustrative of the present invention, but the scope of the present invention is not limited thereto.
EXAMPLE 1 construction of Yeast decoy strains
The sequence fragments of the PnSS promoter, each containing at least one of the major cis-acting elements, were randomly selected and constructed into the pAbAi vector by means of PCR cloning. Specific primers were designed using primer premier 5.0 and alternative restriction sites within the sequence were predicted using SnapGene 3.2.1, selecting SmaI and XhoI restriction enzyme sites. Amplifying the target fragment by using KOD high-fidelity enzyme, and carrying out electrophoretic separation on the PCR product on 1% agarose gel. Then, the target fragment is cut and recovered. The target fragment and the pAbAi vector were digested simultaneously with SmaI and XhoI for 6 hours at 37 ℃ and then 5. mu.L of 10 XDNA loading buffer was added to terminate the digestion reaction. And (3) carrying out electrophoretic separation on the enzyme digestion product on 1% agarose gel, and then carrying out gel cutting recovery treatment.
The fragment of interest was ligated to the vector overnight using T4 ligase and the ligation products were all transformed into E.coli DH5 alpha competent (100. mu.L). And (3) picking the single clone into an LB liquid culture medium (50mg/L Amp), carrying out amplification culture, and then sucking 1 mu L of bacterial liquid as a template to carry out bacterial liquid PCR verification. Verification of the resulting positive clones Plasmid extraction was performed using TIANPure Mini Plasmid Kit II (Code No. DP107) from TIANGEN.
The constructed bait carrier is digested and linearized by BstBI restriction enzyme, and the purified linearized plasmid is transferred into a yeast Y1H strain. Yeast decoy strain identification was performed using the Matchmaker Insert Check PCR Mix I kit. Successfully identified yeast colonies were expanded and selected to give the appropriate yeast decoy strain YS1262 that was inhibited by AbA.
Example 2 screening of genes interacting with PnSS Gene promoter
Panax notoginseng total RNA is extracted according to the instruction of a TIANGEN RNAprep Pure plant total RNA extraction kit. Using total RNA of panax notoginseng as a template, synthesizing a first cDNA chain by SMART reverse transcription, synthesizing double-stranded cDNA by using a long-distance PCR (LD-PCR) amplification technology, detecting by using 1.2% agarose gel electrophoresis, and finally purifying by using a CHROMA SPIN + TE-400 chromatographic column, wherein the panax notoginseng cDNA Library is constructed by referring to the use instruction of a Matchmaker Gold Yeast One-Hybrid Screening System kit.
Co-transforming the purified notoginseng cDNA library and pGADT7 vector into positive bait yeast strain competent cells, culturing at 30 ℃ for 3d on SD/-Leu/AbA (500ng/mL) culture medium, and selecting positive clones to YPDA liquid culture medium for amplification culture. Extracting the yeast plasmid by using a small extraction kit of the Biyuntian yeast plasmid. PCR amplification was performed using the extracted yeast plasmid as a template, using the universal primers T7 (5'-AATACGACTCACTA TAGGGCG-3') and 3-AD (5'-AGATGGTGCACGATGCACAG-3'). The obtained PCR product is sent for sequencing.
And comparing the data obtained by the sequencing result in NCBI and panax notoginseng genomes, transcriptome data and an arabidopsis database to obtain a cytochrome C oxidase 11(cytochrome C oxidase 11, COX11) gene interacted with the PnSS gene promoter, wherein the base sequence is shown as SEQ ID NO.1, and the amino acid sequence of the encoded protein is shown as SEQ ID NO. 2.
Example 3 bioinformatic analysis
The nucleotide and amino acid sequences of the above gene PnCOX11 were submitted to NCBI for analysis. The Open Reading Frame (ORF) sequence of PnCOX11 has 642bp, and encodes 213 amino acids. ExPASY online software (https:// web. ExPASy. org/computer _ pI /) was used to predict a molecular weight of 24335.88Daltons with an isoelectric point (pI) of 8.49, indicating that the protein is a basic protein. Wherein, 26 strong basic Amino Acids (K, R), 23 strong acidic Amino Acids (D, E), 67 Hydrophobic Amino Acids (hydrophosphonic Amino Acids) (A, I, L, F, W, V) and 63 Polar Amino Acids (Polar Amino Acids) (N, C, Q, S, T, Y). PnCOX11 protein had an Instability Index (II) of 53.33, a Total average hydrophilicity (GRAVY) of-0.305, and was a labile hydrophilic protein. The prediction result of SMART online software (http:// SMART. embl-heidelberg. de /) shows that the protein has a transmembrane structure (trans domains) and is positioned at 37-59 aa of the predicted amino acid sequence.
The secondary structure of PnCOX11 protein was predicted using the online software SOPMA (https:// npsa-prabi.ibcp.fr/cgi-bin/npsa _ Automat.pl. The three-dimensional structure of PnCOX11 protein was predicted using the on-line software SWISS-MODEL (http:// swissmodel. expasy. org /), and the results are shown in FIG. 2, using the method NMR. The template number used was 1sp0.1.A, the sequence Identity (Seq Identity) was 49.66%, the oligonucleotide state (Oligo-state) was Monomer, the sequence-to-template sequence similarity (Seq similarity) was 0.45, the Coverage (Coverage) was 0.70, and the predicted sequence was described as a solution structure of apoCOX 11.
The gene PnCOX11 was cloned and analyzed in many species. The amino acid sequence of PnCOX11 and the amino acid sequence of the gene in other plants in the NCBI database are subjected to multi-sequence alignment through software Clustal X and MEGA6.0 to construct an evolutionary tree, and specific species and protein sequence numbers are shown in Table 1. According to the evolutionary tree results (FIG. 3), PnCOX11 is grouped with NaCOX11 of the model plant Nicotiana, both dicotyledonous plants.
TABLE 1 nucleotide sequences for construction of evolutionary trees
Example 4 in vivo yeast validation
Based on the result of the single hybridization of yeast, the gene sequence interacting with the PnSS promoter was selected as the target of in vivo yeast assay. Specific primers (upstream primer: 5'-CGGAATTCATGCCACGATGTGATTTGCCA-3' and downstream primer: 5'-CGGGATCCTTATTCTTCAGAAACCTTGAAAAA-3') are designed according to panax notoginseng transcriptome data, EcoRI and BamHI enzyme cutting sites are introduced into sequences, panax notoginseng cDNA is used as a template, and genes are constructed into pGADT7 vectors through PCR amplification. The constructed recombinant vectors were transferred into the yeast strain YS1262, respectively, and the interaction between PnCOX11 and PnSS promoter was verified by X- α -gal color reaction (FIG. 4).
Example 5 in vitro validation
Designing a specific primer (an upstream primer: 5'-CGGGATCCATGCCACGATGTGATTTGCCA-3' and a downstream primer: 5'-CGGAATTCTTATTCTTCAGAAACCTTGAAAAA-3') according to the panax notoginseng transcriptome data, introducing BamHI and EcoRI enzyme cutting sites into a sequence, and constructing PnCOX11 into a prokaryotic expression vector pET-32a by PCR amplification by taking panax notoginseng cDNA as a template. Extracting positive recombinant plasmid, and transforming competent cells of Escherichia coli BL21(DE 3). Positive clones were selected with LB medium (50mg/L Amp) containing antibiotics. Inoculating 200 mu L of the positive clone bacterial liquid into 5mL of LB liquid medium for amplification culture, and adding IPTG (isopropyl-beta-D-thiogalactoside) to induce and express the recombinant protein when the bacterial liquid reaches logarithmic growth period (OD600 is 0.5), wherein the concentration of the IPTG is 1mmol/L, the appropriate induction time is 6h, and the induction temperature is 25 ℃. Finally, the obtained protein was subjected to gel electrophoresis using SDS-PAGE gel electrophoresis technique, and the results are shown in FIG. 5.
The size of the PnCOX11 fusion protein was 37kD, and after removal of the His tag protein, the band size matched the predicted size of the PnCOX11 protein, which was approximately 24 kD.
Example 6 subcellular localization
Specific primers (upstream primer: 5'-TCCCCCGGGATGCCACGATGTGATTTGCCA-3' and downstream primer: 5'-CGGGATCCTTCTTCAGAAACCTTGAAAAAGGTA-3') are designed according to panax notoginseng transcriptome data, SmaI and BamHI enzyme cutting sites are introduced into sequences, and genes are constructed into a 35S-sGFP vector by PCR amplification by taking panax notoginseng cDNA as a template. The constructed recombinant vector was transformed into E.coli DH5 alpha competence. And (3) picking the single clone into an LB liquid culture medium (50mg/L Kan), carrying out amplification culture, and then sucking 1 mu L of bacterial liquid as a template to carry out bacterial liquid PCR verification. The positive clones obtained were verified to be extracted with the Plasmid using TIANPure Mini Plasmid Kit II (Code No. DP107) from TIANGEN, and then transformed into Agrobacterium tumefaciens strain GV 3101. The agrobacterium H2B-RFP strain and GV3101 strain containing the target gene were mixed according to the ratio of 1: 1, and injecting the mixture into the same tobacco leaf, wherein the H2B-RFP strain can make the cell nucleus appear red. The tobacco after injection was cultured for 3 days, and then sampled and observed under a confocal laser microscope. Subcellular localization results showed that the fluorescence of PnCOX11 protein was as highly similar to chloroplast fluorescence, indicating that it is predominantly localized in chloroplasts (fig. 6).
Sequence listing
<110> Zhejiang university of science and engineering
<120> gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside
<160> 10
<170> SIPOSequenceListing 1.0
<210> 1
<211> 642
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 1
atgccacgat gtgatttgcc acaattaaga actcggagtt cttgttattt gcctggattt 60
cgccgccaat atgctactca tgctgctaca gaaaaaaaat caaaaaagat gcttatatat 120
ttaactggat tggtttttgc tatggtggga tgtagttatg ctgcagttcc tctgtatagg 180
agattttgtc aagctactgg ttatgggggt actgttcagc gtcgtgagag tgttgaagaa 240
aagatcactc ggcatgctca agatggaaca gttaccagca gggagatcgt ggtgcagttc 300
aatgctgatg ttgctgatgg aatgccttgg aagtttgttc caacacagag agaggtaagg 360
gtcaagccag gagagagtgc tcttgctttt tacacagctg aaaatcgaag ctcaacaccc 420
attactggca tatctacata caacgttacc cctatgaagg ctgcagttta tttcaacaaa 480
atacaatgct tttgcttcga ggagcagaga cttctacctg gggagcagat tgacatgcct 540
gtattctttt acatagaccc tgaatttgaa accgattcaa gaatggatgg tatcaacaac 600
atgattctgt cctatacctt tttcaaggtt tctgaagaat aa 642
<210> 2
<211> 213
<212> PRT
<213> Artificial Sequence (Artificial Sequence)
<400> 2
Met Pro Arg Cys Asp Leu Pro Gln Leu Arg Thr Arg Ser Ser Cys Tyr
1 5 10 15
Leu Pro Gly Phe Arg Arg Gln Tyr Ala Thr His Ala Ala Thr Glu Lys
20 25 30
Lys Ser Lys Lys Met Leu Ile Tyr Leu Thr Gly Leu Val Phe Ala Met
35 40 45
Val Gly Cys Ser Tyr Ala Ala Val Pro Leu Tyr Arg Arg Phe Cys Gln
50 55 60
Ala Thr Gly Tyr Gly Gly Thr Val Gln Arg Arg Glu Ser Val Glu Glu
65 70 75 80
Lys Ile Thr Arg His Ala Gln Asp Gly Thr Val Thr Ser Arg Glu Ile
85 90 95
Val Val Gln Phe Asn Ala Asp Val Ala Asp Gly Met Pro Trp Lys Phe
100 105 110
Val Pro Thr Gln Arg Glu Val Arg Val Lys Pro Gly Glu Ser Ala Leu
115 120 125
Ala Phe Tyr Thr Ala Glu Asn Arg Ser Ser Thr Pro Ile Thr Gly Ile
130 135 140
Ser Thr Tyr Asn Val Thr Pro Met Lys Ala Ala Val Tyr Phe Asn Lys
145 150 155 160
Ile Gln Cys Phe Cys Phe Glu Glu Gln Arg Leu Leu Pro Gly Glu Gln
165 170 175
Ile Asp Met Pro Val Phe Phe Tyr Ile Asp Pro Glu Phe Glu Thr Asp
180 185 190
Ser Arg Met Asp Gly Ile Asn Asn Met Ile Leu Ser Tyr Thr Phe Phe
195 200 205
Lys Val Ser Glu Glu
210
<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 3
aatacgactc actatagggc g 21
<210> 4
<211> 20
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 4
agatggtgca cgatgcacag 20
<210> 5
<211> 29
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 5
cggaattcat gccacgatgt gatttgcca 29
<210> 6
<211> 32
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 6
cgggatcctt attcttcaga aaccttgaaa aa 32
<210> 7
<211> 29
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 7
cgggatccat gccacgatgt gatttgcca 29
<210> 8
<211> 32
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 8
cggaattctt attcttcaga aaccttgaaa aa 32
<210> 9
<211> 30
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 9
tcccccggga tgccacgatg tgatttgcca 30
<210> 10
<211> 33
<212> DNA
<213> Artificial Sequence (Artificial Sequence)
<400> 10
cgggatcctt cttcagaaac cttgaaaaag gta 33
Claims (9)
1.A gene PnCOX11 is characterized in that the nucleotide sequence of the gene is shown in SEQ ID NO. 1.
2. A recombinant expression vector comprising the gene PnCOX11 of claim 1.
3. A genetically engineered bacterium comprising the gene PnCOX11 of claim 1.
4. A cytochrome C oxidase 11, wherein the amino acid sequence of the cytochrome C oxidase 11 is represented by SEQ ID NO. 2.
5. Cytochrome C oxidase 11 as claimed in claim 4, which is obtained by encoding the gene PnCOX11 having the nucleotide sequence shown in SEQ ID No. 1.
6. Use of the gene PnCOX11 according to claim 1 or of the cytochrome C oxidase 11 according to claim 4 for interacting with the promoter of the gene PnSS.
7. The use of the gene PnCOX11 as defined in claim 1 or the genetically engineered bacterium as defined in claim 3 for regulating and controlling the synthesis of notoginsenoside.
8. The use of claim 7, wherein the regulatory pathway is: the protein coded by the gene PnCOX11 is combined with the promoter of the gene PnSS to regulate and control the synthesis of notoginsenoside.
9. Use of cytochrome C oxidase 11 as claimed in any of claims 4 or 5 for regulating the synthesis of notoginsenoside.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111181146.7A CN114058632A (en) | 2021-10-11 | 2021-10-11 | Gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111181146.7A CN114058632A (en) | 2021-10-11 | 2021-10-11 | Gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114058632A true CN114058632A (en) | 2022-02-18 |
Family
ID=80234223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111181146.7A Pending CN114058632A (en) | 2021-10-11 | 2021-10-11 | Gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114058632A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113652426A (en) * | 2021-08-20 | 2021-11-16 | 昆明理工大学 | Panax notoginseng inducible promoter R1 and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102517297A (en) * | 2011-12-22 | 2012-06-27 | 四川农业大学 | Rice rhizoctonia solani effector gene AG1IA06910 and application thereof |
WO2016109758A2 (en) * | 2014-12-30 | 2016-07-07 | Symbiota, LLC | Seed endophytes across cultivars and species, associated compositions, and methods of use thereof |
CN106497939A (en) * | 2016-10-14 | 2017-03-15 | 昆明理工大学 | A kind of Radix Notoginseng transcription factor gene PnMYB1 and its application |
-
2021
- 2021-10-11 CN CN202111181146.7A patent/CN114058632A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102517297A (en) * | 2011-12-22 | 2012-06-27 | 四川农业大学 | Rice rhizoctonia solani effector gene AG1IA06910 and application thereof |
WO2016109758A2 (en) * | 2014-12-30 | 2016-07-07 | Symbiota, LLC | Seed endophytes across cultivars and species, associated compositions, and methods of use thereof |
CN106497939A (en) * | 2016-10-14 | 2017-03-15 | 昆明理工大学 | A kind of Radix Notoginseng transcription factor gene PnMYB1 and its application |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113652426A (en) * | 2021-08-20 | 2021-11-16 | 昆明理工大学 | Panax notoginseng inducible promoter R1 and application thereof |
CN113652426B (en) * | 2021-08-20 | 2023-06-20 | 昆明理工大学 | Pseudo-ginseng inducible promoter R1 and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105087601B (en) | A kind of application of panax japonicus majoris transcription factor gene PjWRKY1 | |
CN107012164A (en) | CRISPR/Cpf1 Plant Genome directed modifications functional unit, the carrier comprising the functional unit and its application | |
CN105087599B (en) | A kind of application of panax japonicus majoris transcription factor gene PjERF1 | |
CN106497939B (en) | A kind of Radix Notoginseng transcription factor gene PnMYB1 and its application | |
CN109055399B (en) | Gene sequence related to flavone composition in scutellaria baicalensis and application thereof | |
CN113005139B (en) | Application of transcription factor PsMYB1 in regulation and control of synthesis of peony petal anthocyanin | |
CN110343157B (en) | Cotton verticillium wilt related gene GhBONI and encoding protein and application thereof | |
CN107955067B (en) | Two MYB transcription factors involved in peach flavonol biosynthesis regulation and control and application thereof | |
CN111363020A (en) | MYC2 transcription factor of tea tree and application thereof | |
CN109486831B (en) | Carmine radish anthocyanin biosynthesis regulatory gene RsAN1 and application thereof | |
CN106220719B (en) | Artemisia apiacea bHLH transcription factor coding sequence, cloning method and application | |
CN105087600B (en) | A kind of application of panax japonicus majoris transcription factor gene PjbHLH1 | |
Xia et al. | Structural and interactions analysis of a transcription factor PnMYB2 in Panax notoginseng | |
CN114058632A (en) | Gene PnCOX11 and application thereof in regulating and controlling synthesis of notoginsenoside | |
CN101413006B (en) | Drought-induced rice flower specific promoter and use thereof | |
CN114058627A (en) | Gene PnMYB2 and application thereof in regulating and controlling synthesis of notoginsenoside | |
CN106047895B (en) | Artemisia apiacea bZIP transcription factor coding sequence, cloning method and application | |
XU et al. | OsPIN1a gene participates in regulating negative phototropism of rice roots | |
CN114058628A (en) | Gene PnWRKY1 and application thereof in regulating and controlling synthesis of notoginsenoside | |
TWI480375B (en) | Glycosyltransferase promoter from a medicinal herb on gene regulation and application | |
CN106047897B (en) | Artemisia apiacea bHLH transcription factor coding sequence, cloning method and application | |
CN113846106B (en) | Gene PnDCD and application thereof in regulating and controlling saponin synthesis | |
CN109971744B (en) | Malan blue BcTSA gene and encoded protein and application thereof | |
CN106967735B (en) | Safflower CtCHS1 gene, and coding protein and application thereof | |
CN106086038B (en) | Artemisia apiacea WRKY transcription factor coding sequence, cloning method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |